The global polyclonal antibody market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). These antibodies are defined as a composition of a mixture of antibodies that correspond to the natural immune response to an antigen and are highly used in general research applications. The major factor attributable to the market growth includes the increasing application of polyclonal antibody in various research applications. Adding to this, the rising incidence of cancer backed by the significant rise in awareness campaigns and research funding on cancer, is likely to boost further use of polyclonal antibodies in the disease treatment. For instance, in 2018, the UK Government funded around $300 million for cancer treatment. Further, key initiatives by the market players also provide a major boost to the market growth. For instance, in March 2020, GigaGen, Inc., a biotechnology company, announced that it has developed a recombinant polyclonal antibody therapy for the treatment of COVID-19.
To Request a Sample of our Report on Polyclonal Antibody Market: https://www.omrglobal.com/request-sample/polyclonal-antibody-market
Some key players operating in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and PerkinElmer, Inc., among others. The market players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, investment in research and development, and so on. For instance, in August 2018, SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, announced that its anti-Ebola immunotherapy, SAB-139, offers100% protection against a lethal dose of the Ebola virus in an animal study published in The Journal of Infectious Diseases. The study was conducted by the National Interagency Confederation for Biological Research in collaboration with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC).
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Thermo Fisher Scientific Inc., Agilent Technologies, Inc., and PerkinElmer, Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Polyclonal Antibody Market is Available @ https://www.omrglobal.com/industry-reports/polyclonal-antibody-market
Global Polyclonal Antibody Market Report by Segment
By Type
- Primary Antibody
- Secondary Antibody
By Application
- Academic Research
- Commercial
Global Polyclonal Antibody Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
